메뉴 건너뛰기




Volumn 35, Issue 5, 2009, Pages 475-480

Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors

Author keywords

Aromatase inhibitor; Bone mineral density; Dual X ray absorptiometry scan; Fragility fracture risk; Oestrogen receptor positive breast cancer; Osteoporosis

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; TAMOXIFEN;

EID: 63049139040     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.08.001     Document Type: Article
Times cited : (4)

References (27)
  • 1
    • 0026446492 scopus 로고
    • Melton LJ III. Hip fractures in the elderly: a worldwide projection
    • Cooper C., and Campion G. Melton LJ III. Hip fractures in the elderly: a worldwide projection. Osteoporosis Int 2 (1992) 285-289
    • (1992) Osteoporosis Int , vol.2 , pp. 285-289
    • Cooper, C.1    Campion, G.2
  • 2
    • 23844436308 scopus 로고    scopus 로고
    • Aging bones: osteoporosis and injurious falls in the oldest women
    • Heffernan J.D., and Messinger-Rapport B.J. Aging bones: osteoporosis and injurious falls in the oldest women. Clin Rev Bone and Miner Metab 3 2 (2005) 157-173
    • (2005) Clin Rev Bone and Miner Metab , vol.3 , Issue.2 , pp. 157-173
    • Heffernan, J.D.1    Messinger-Rapport, B.J.2
  • 3
    • 0029981702 scopus 로고    scopus 로고
    • Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population
    • Miller P.D., Bonnick S.L., and Rosen C.J. Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population. Calcif Tissue Int 58 (1996) 207-214
    • (1996) Calcif Tissue Int , vol.58 , pp. 207-214
    • Miller, P.D.1    Bonnick, S.L.2    Rosen, C.J.3
  • 4
    • 34147123172 scopus 로고    scopus 로고
    • Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences
    • Boonen S. Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences. Bone 40 (2007) S26-S31
    • (2007) Bone , vol.40
    • Boonen, S.1
  • 5
    • 9144233479 scopus 로고    scopus 로고
    • The effects of strontium ranelate on risk of vertebral fracture in women with postmenopausal osteoporosis
    • Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
    • (2004) N Engl J Med , vol.350 , pp. 459-468
    • Meunier, P.J.1    Roux, C.2    Seeman, E.3
  • 6
    • 21044447888 scopus 로고    scopus 로고
    • Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: TROPOS study
    • Reginster J., Seeman E., Vernejoul M., et al. Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: TROPOS study. J Clin Endocrinol Metab 90 (2005) 2816-2822
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 2816-2822
    • Reginster, J.1    Seeman, E.2    Vernejoul, M.3
  • 8
    • 14844292675 scopus 로고    scopus 로고
    • Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study
    • Chen Z., Maricic M., Bassford T.L., et al. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 165 6 (2005) 552-558
    • (2005) Arch Intern Med , vol.165 , Issue.6 , pp. 552-558
    • Chen, Z.1    Maricic, M.2    Bassford, T.L.3
  • 9
    • 24944500572 scopus 로고    scopus 로고
    • Bone loss and the aromatase inhibitors
    • Lester J., and Coleman R. Bone loss and the aromatase inhibitors. Br J Cancer 93 suppl 1 (2005) S16-S22
    • (2005) Br J Cancer , vol.93 , Issue.SUPPL. 1
    • Lester, J.1    Coleman, R.2
  • 10
    • 20044382779 scopus 로고    scopus 로고
    • American Society of Clinical Oncology Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004
    • Winer E.P., Hudis C., Burstein H.J., et al. American Society of Clinical Oncology Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23 23 (2005) 619-629
    • (2005) J Clin Oncol , vol.23 , Issue.23 , pp. 619-629
    • Winer, E.P.1    Hudis, C.2    Burstein, H.J.3
  • 11
    • 0642342669 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
    • Hillner B., Ingle J., Chlebowski R., et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21 21 (2003) 4042-4057
    • (2003) J Clin Oncol , vol.21 , Issue.21 , pp. 4042-4057
    • Hillner, B.1    Ingle, J.2    Chlebowski, R.3
  • 12
    • 33747605310 scopus 로고    scopus 로고
    • NCCN Task force report: bone health and cancer care
    • Theriault R.L., Biermann J.S., Brown E., et al. NCCN Task force report: bone health and cancer care. J Nat Comp Cancer Netw 4 suppl 2 (2006) S1-S22
    • (2006) J Nat Comp Cancer Netw , vol.4 , Issue.SUPPL. 2
    • Theriault, R.L.1    Biermann, J.S.2    Brown, E.3
  • 13
    • 1642391691 scopus 로고    scopus 로고
    • The Writing Group for the ISCD Position Development Conference. Position statement. Introduction, methods and participants
    • The Writing Group for the ISCD Position Development Conference. Position statement. Introduction, methods and participants. J Clin Densitom 7 1 (2004) 13-15
    • (2004) J Clin Densitom , vol.7 , Issue.1 , pp. 13-15
  • 15
    • 0034760560 scopus 로고    scopus 로고
    • Prediction equations to estimate glomerular filtration rate: an update
    • Manjunath G., Sarnak M.J., and Levey A.S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertension 10 (2001) 785-792
    • (2001) Curr Opin Nephrol Hypertension , vol.10 , pp. 785-792
    • Manjunath, G.1    Sarnak, M.J.2    Levey, A.S.3
  • 16
    • 0026585852 scopus 로고
    • Effects of tamoxifen on bone mineral density in post-menopausal women with breast cancer
    • Love R.R., Mazess R.B., Barden H.S., et al. Effects of tamoxifen on bone mineral density in post-menopausal women with breast cancer. N Engl J Med 326 (1992) 852-856
    • (1992) N Engl J Med , vol.326 , pp. 852-856
    • Love, R.R.1    Mazess, R.B.2    Barden, H.S.3
  • 18
    • 0029858793 scopus 로고    scopus 로고
    • Bone Mineral Density and risk of breast cancer in older women: the study ofosteoporotic fractures. Study of osteoporotic fractures research group
    • Cauley J.A., Lucas F.L., Kuller J.H., et al. Bone Mineral Density and risk of breast cancer in older women: the study ofosteoporotic fractures. Study of osteoporotic fractures research group. JAMA 276 17 (1996) 1404-1408
    • (1996) JAMA , vol.276 , Issue.17 , pp. 1404-1408
    • Cauley, J.A.1    Lucas, F.L.2    Kuller, J.H.3
  • 20
    • 33746455931 scopus 로고    scopus 로고
    • The ATAC trialist's Group. Effect of an AI on BMD and bone turnover markers: 2-year results of the anastrozole, Tamoxifen alone or in combination (ATAC) trial
    • Eastell R., Hannon R.A., Cuzick J., Dowsett M., Clack G., and Adams J.E. The ATAC trialist's Group. Effect of an AI on BMD and bone turnover markers: 2-year results of the anastrozole, Tamoxifen alone or in combination (ATAC) trial. J Bone Miner Res 21 8 (2006) 1215-1223
    • (2006) J Bone Miner Res , vol.21 , Issue.8 , pp. 1215-1223
    • Eastell, R.1    Hannon, R.A.2    Cuzick, J.3    Dowsett, M.4    Clack, G.5    Adams, J.E.6
  • 21
    • 0141527583 scopus 로고    scopus 로고
    • Is the paradigm shifting?
    • Heaney R.P. Is the paradigm shifting?. Bone 33 4 (2003) 457-465
    • (2003) Bone , vol.33 , Issue.4 , pp. 457-465
    • Heaney, R.P.1
  • 22
    • 27444437924 scopus 로고    scopus 로고
    • Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study
    • Sornay-Rendu E., Munoz F., Duboeuf F., and Delmas P.D. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J Bone Miner Res 20 11 (2005) 1929-1935
    • (2005) J Bone Miner Res , vol.20 , Issue.11 , pp. 1929-1935
    • Sornay-Rendu, E.1    Munoz, F.2    Duboeuf, F.3    Delmas, P.D.4
  • 23
    • 0032835427 scopus 로고    scopus 로고
    • Fracture risk in primary hyperparathyroidism
    • Khosla S., and Melton J. Fracture risk in primary hyperparathyroidism. J Bone Miner Res 14 10 (1999) 1700-1707
    • (1999) J Bone Miner Res , vol.14 , Issue.10 , pp. 1700-1707
    • Khosla, S.1    Melton, J.2
  • 24
    • 33845807308 scopus 로고    scopus 로고
    • Primary hyperparathyroidism is common in postmenopausal women with forearm fracture and low bone mineral density
    • Bergstrom I., Landgren B.M., and Freyschuss B. Primary hyperparathyroidism is common in postmenopausal women with forearm fracture and low bone mineral density. Acta Obstet Gynecol Scand 86 1 (2007) 61-64
    • (2007) Acta Obstet Gynecol Scand , vol.86 , Issue.1 , pp. 61-64
    • Bergstrom, I.1    Landgren, B.M.2    Freyschuss, B.3
  • 25
    • 0029928837 scopus 로고    scopus 로고
    • Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
    • Garnero P., Sornay-Rendu E., Chapuy M.-C., and Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11 3 (1996) 337-349
    • (1996) J Bone Miner Res , vol.11 , Issue.3 , pp. 337-349
    • Garnero, P.1    Sornay-Rendu, E.2    Chapuy, M.-C.3    Delmas, P.D.4
  • 26
    • 0038059244 scopus 로고    scopus 로고
    • Vitamin D in preventive medicine: are we ignoring the evidence?
    • Zitterman A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br J Nutrition 89 (2003) 552-572
    • (2003) Br J Nutrition , vol.89 , pp. 552-572
    • Zitterman, A.1
  • 27
    • 33750522464 scopus 로고    scopus 로고
    • Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomized placebo-controlled study
    • Geisler J., Lønning P.E., Kraq L.E., et al. Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomized placebo-controlled study. Eur J Cancer 42 (2006) 2968-2975
    • (2006) Eur J Cancer , vol.42 , pp. 2968-2975
    • Geisler, J.1    Lønning, P.E.2    Kraq, L.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.